tiprankstipranks
Trending News
More News >
OnKure Therapeutics (OKUR)
NASDAQ:OKUR
US Market
Advertisement

OnKure Therapeutics (OKUR) Income Statement

Compare
403 Followers

OnKure Therapeutics Income Statement

Last quarter (Q3 2025), OnKure Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, OnKure Therapeutics's net income was $-14.70M. See OnKure Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ -50.00K$ -37.00K
Operating Expenses
$ 54.39M$ 36.93M$ 29.77M$ 39.77M$ 19.52M
Depreciation and Amortization
$ 662.00K$ 560.00K$ 387.00K$ 50.00K$ 37.00K
EBITDA
$ -51.71M$ -34.75M$ -29.38M$ -39.72M$ -19.43M
Operating Income
$ -54.39M$ -36.93M$ -29.77M$ -39.82M$ -19.55M
Other Income/Expenses
$ 1.71M$ 1.62M$ 254.00K$ 48.00K$ 87.00K
Pretax Income
$ -52.67M$ -35.31M$ -29.51M$ -39.77M$ -19.46M
Net Income
$ -52.67M$ -35.31M$ -29.51M$ -39.77M$ -19.46M
Per Share Metrics
Basic EPS
$ -3.95$ -2.65$ -2.21$ -21.92$ -7.74
Diluted EPS
$ -3.95$ -2.65$ -2.21$ -21.92$ -7.74
Weighted Average Shares Outstanding
13.34M 13.34M 13.34M 1.81M 2.51M
Weighted Average Shares Outstanding (Diluted)
13.34M 13.34M 13.34M 1.81M 2.51M
Currency in USD

OnKure Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis